Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
In Post-Herpetic Neuralgia(PHN) patients:
- To conduct an explorative investigation of the efficacy and safety of repeated oral
doses of TRK-700 via a randomized double blind comparative study
- To measure the plasma concentration of TRK-700 and its metabolites